Quick answers
- What is Ritalin LA?
- Ritalin LA is a brand name of Methylphenidate, a prescription medicine. The FDA NDC Directory lists 4 Ritalin LA products in 4 strengths and forms.
- Who makes Ritalin LA?
- Sandoz holds the FDA application for Ritalin LA (NDA021284, approved June 5, 2002).
- Is there a generic or store brand of Ritalin LA?
- Yes. The FDA NDC Directory lists 44 other products with the same active ingredients, strength and form as a Ritalin LA product, 36 of them generic. Ask your pharmacist whether one is right for you.
- Has Ritalin LA been recalled?
- No recall linked to Ritalin LA products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Ritalin LA is
Each Ritalin LA product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Methylphenidate · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| methylphenidate hydrochloride 10 mg capsule, extended release (oral) | Ritalin LA | 11 products, 9 companies | DailyMed |
| methylphenidate hydrochloride 20 mg capsule, extended release (oral) | Ritalin LA | 11 products, 9 companies | DailyMed |
| methylphenidate hydrochloride 30 mg capsule, extended release (oral) | Ritalin LA | 11 products, 9 companies | DailyMed |
| methylphenidate hydrochloride 40 mg capsule, extended release (oral) | Ritalin LA | 11 products, 9 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Methylphenidate →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA021284 | Sandoz | June 5, 2002 | 4 |
Companies that list Ritalin LA
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Ritalin LA products.
- Novartis Pharmaceuticals Corporation4 products
Recalls
No recall linked to Ritalin LA products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.